GET DAILY SIGNALSGCM Grosvenor Inc. (GCMG): Assessing the Path to the $15 Analyst Target
Key Takeaways
- The central stock price target of $15 is the arithmetic mean of four verified analyst price targets from J.P. Morgan, Piper Sandler, TD Cowen, and Oppenheimer.
- At a recent price near $13.37, reaching $15 would require a rise of approximately 12%.
- The analyst price target range is wide, spanning $13 (J.P. Morgan) to $17 (Oppenheimer), reflecting genuine disagreement about the firm's growth and valuation.
- Supporting factors include roughly $97 billion in assets under management (AUM), strong fee-revenue growth, and a push into credit secondaries and wealth-channel distribution.
- Principal risks include the lumpy timing of performance fees and carried interest, balance-sheet leverage, and recent downward target revisions from two bullish firms.
- You can track the latest developments on Tickeron's Major News, Today's Price Move, Forecast, and Earnings pages.
- For broader market ideas and automated trading strategies, explore Trending AI Robots.
Analyst Price Targets and Consensus View
Four firms currently publish numeric 12-month price targets for GCMG, while a fifth — William Blair — rates the shares Buy without attaching a figure. The four targets are J.P. Morgan at $13 (Hold), Piper Sandler at $15 (Overweight), TD Cowen at $16 (Buy), and Oppenheimer at $17 (Outperform). Averaging these values produces a mean of roughly $15.25, which rounds to the $15 central target used here. The range runs from $13 to $17.
The dispersion matters. J.P. Morgan holds a cautious stance, viewing the shares as fairly valued near current levels. At the opposite end, Oppenheimer and TD Cowen emphasize durable fee-revenue momentum and asset growth. Notably, even the bulls trimmed expectations in October 2026: Oppenheimer lowered its target from $18 to $17, and Piper Sandler reduced its target from $16 to $15 while both retained Buy-equivalent ratings. That pattern suggests constructive, but more measured, conviction than earlier in the year. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path Toward the Target
With shares near $13.37 and the central target at $15, the required move is about 12% — a modest advance that would still leave the stock roughly in line with its 52-week high near $14.87 and below the most optimistic analyst forecast. The path to $15 would likely depend on continued fee-related revenue growth, stable or rising AUM, and a firming in valuation rather than any single catalyst. The shares have been volatile, trading in a wide band between $9.30 and $14.87 over the past year.
What Could Support a Move Toward the Target
GCM Grosvenor reported roughly $97 billion in AUM as of mid-2026, and fee-related revenue — the core recurring driver that excludes volatile performance fees — grew about 21% year over year in the second quarter. The firm raised approximately $1.2 billion for a first credit secondaries fund and has expanded its wealth-management distribution, including a September 2026 partnership with Hyperion Realty Capital. A quarterly dividend of $0.12 per share (a yield near 3.6%) provides income support. Consensus estimates project low-double-digit revenue growth and stronger earnings expansion in the coming year, which underpins the more optimistic price forecasts.
What Could Prevent the Target From Being Reached
The primary obstacles are tied to the nature of alternative-asset economics. Performance fees and carried interest are inherently lumpy and difficult to time, and one-off "catch-up" fees can obscure underlying trends. The firm also carries meaningful balance-sheet leverage, which raises sensitivity to credit conditions and interest-rate moves. Competition in alternative asset management is intense, and the October target reductions from Oppenheimer and Piper Sandler signal that even supportive analysts see less near-term upside than before. A slowdown in fundraising or fee-paying AUM conversion would directly pressure the stock forecast.
Technical Levels and Market Structure
The 52-week high near $14.87 represents the clearest resistance level — and it sits just below the $15 central target, meaning any advance toward that objective would first have to clear prior peaks. On the downside, the $12.50-to-$13 zone, which includes J.P. Morgan's target and recent consolidation, has acted as a support area. The $9.30 52-week low is a deeper reference point. The stock's wide annual range underscores elevated volatility relative to many larger financial names. From what I see, monitoring these levels closely helps frame realistic expectations around the $15 objective.
Time Horizon and What Investors Should Monitor
Analyst price targets generally reflect a research horizon of about 12 months, though individual assumptions vary and no single target is a guarantee. Investors should watch quarterly results — particularly fee-related revenue, AUM and net flows, and the conversion of contracted but not-yet-fee-paying assets — along with analyst target revisions, Federal Reserve interest-rate policy, and developments in credit and wealth-channel fundraising. Because performance fees are lumpy, focusing on recurring fee trends offers a clearer read on the underlying business than headline earnings alone. I’m watching this closely as earnings approach.
Using AI Daily Buy/Sell Signals in Research
In my research process, I often turn to Tickeron's AI Daily Buy/Sell Signals to get an additional data-driven perspective on short-term momentum. This tool uses artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. It helps me spot shifting trends more efficiently when evaluating names like GCMG alongside longer-horizon analyst targets.
Final Assessment
The $15 central target is a calculated average of four current analyst price targets, not a published consensus or a prediction, and it implies a modest gain of roughly 12% from recent levels. Support comes from growing AUM, strong fee-revenue momentum, and strategic expansion into credit and wealth channels, while the wide $13-to-$17 analyst range, lumpy performance-fee economics, balance-sheet leverage, and recent target cuts temper the outlook. Whether the stock reaches $15 will depend most on sustained fee growth, fundraising momentum, and how the market re-rates the shares against a 52-week high that sits just below that level. Investors should weigh these factors against their own objectives and risk tolerance rather than treating any single price objective as a certainty.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GCMG sees its Stochastic Oscillator ascending out of oversold territory
On October 30, 2026, the Stochastic Oscillator for GCMG moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 45 instances where the indicator left the oversold zone. In 33 of the 45 cases the stock moved higher in the following days. This puts the odds of a move higher at over 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on GCMG as a result. In 54 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for GCMG just turned positive on October 30, 2026. Looking at past instances where GCMG's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.
Following a +2.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where GCMG advanced for three days, in 194 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
GCMG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
GCMG moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GCMG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for GCMG entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 6 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 49 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. GCMG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GCMG's P/B Ratio (30.541) is very high in comparison to the industry average of (2.412). P/E Ratio (16.025) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (2.700) is also within normal values, averaging (1.319). Dividend Yield (0.038) settles around the average of (0.270) among similar stocks. P/S Ratio (4.417) is also within normal values, averaging (15.694).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InvestmentManagers
Advertisement